Breeze Meds Tirzepatide Review: Cost, the Dose Floor & Honest Verdict (2026)

Breeze Meds is a LegitScript-certified nationwide compounded telehealth program whose homepage advertises weight-loss injections "starting at $199" without naming a specific molecule — this review confirmed that figure live, attached to a generic GLP-1 injection product image rather than a tirzepatide-specific listing. What you buy once you reach the plan selector is genuinely all-in: consult, medication, supplies, shipping, and support in one price, with nothing charged until a provider approves you. The catch is dose: every quoted figure is for the lowest strength, and the site states plainly that higher doses may cost more. Every fact here comes from the company's own published program.

What Breeze Meds is

Breeze Meds is a LegitScript-certified nationwide telehealth program, and independently verified: its LegitScript seal image is served directly from LegitScript's own CDN (static.legitscript.com), a genuinely stronger technical signal than the self-hosted badges several sibling providers in this category use. GLP-1 treatment is confirmed available nationwide, described on the site as reaching all 50 states. Nothing is charged until a licensed provider approves your treatment, and the consult itself is free if you proceed.

The homepage price doesn't name a molecule — and every figure is a floor

Breeze Meds' homepage displays "Starting at $199" attached to a generic GLP-1 injection product image — the headline doesn't say which drug that figure applies to. The specific tirzepatide price only appears once you reach the plan selector inside the site's booking flow. Tirzepatide is quoted there at $299 for a first month, reverting to $399/month thereafter, or $1,068 for three months — inclusive of consult, medication, supplies, and shipping, but priced specifically at the lowest dose. The funnel states higher doses may cost more, so whatever figure you see at signup is a floor, not the price of a therapeutic dose you eventually titrate to. Confirm the current figure directly with Breeze Meds, since this review's live pass could not independently reconfirm the plan-selector pricing behind the intake.

The brand-vs-compounded question

Breeze Meds dispenses compounded tirzepatide, not the FDA-approved branded product (Mounjaro or Zepbound). Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the full regulatory picture.

How the care model holds up

Breeze Meds' real strengths: nothing is charged until a provider approves you, the consult is free if you proceed, and what you buy is genuinely all-in — one figure covering consult, medication, supplies, and shipping rather than several line items. Its LegitScript seal is genuinely verified, and it's available nationwide. The trade-offs worth internalizing: every quoted price is for the lowest dose, with the funnel stating outright that higher doses may cost more, and no tirzepatide price is published anywhere on the public homepage — the generic "$199 starting at" figure doesn't name tirzepatide specifically, so you need to enter the intake to see a real number. As with any GLP-1 program, get the price at your actual expected dose in writing before you commit; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Breeze Meds is worth considering for its genuinely all-in pricing structure, a real LegitScript seal, and a no-charge-until-approved model — but treat every advertised figure as the lowest-dose floor, not the price you'll actually pay once titrated to a therapeutic dose. If you want a flat rate that doesn't escalate by dose, compare it against CoreAge Rx, whose figure is published outright. Oak advertises "one price, all dosages" as well, but publishes nine conflicting starting figures with no term attached to any of them, so the claim cannot be checked before you start its intake. See our best tirzepatide providers ranking for the full field.